Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Harvard Scientific acquires rights to oral treatment for sexual dysfunction

June 19, 1998

Lilly continues R&D focus on compounds for postmenopausal syndrome

June 19, 1998

BioTime's PentaLyte reduces hypovolemic injury in preclinical study

June 19, 1998

Zonagen reaches milestone for Vasomax

June 18, 1998

Karo Bio and the University of California expand license agreement

June 18, 1998

Phase IIb results presented for pulmonary insulin

June 18, 1998

Kyowa Hakko claims new agents for thrombocytopenia

June 18, 1998

Research into new tocolytic agents continues at Merck & Co.

June 18, 1998

Antidiabetic activity of S-3483, a site-specific inhibitor of Glc-6-Pase

June 18, 1998

Orally active and potent GH secretagogue discovered by Merck & Co.

June 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...